Tag: Pricing

GV60 is the first all-electric Genesis to be introduced in the UK Pricing starts from £47,005 for the Premium and top at £65,405 for the Sport PlusLondon, UK: Genesis Motor ...

BOSTON, April 28, 2022 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced the pricing of its upsized initial ...

GUELPH, ON and LONGUEUIL, QC, April 27, 2022 (GLOBE NEWSWIRE) -- Grain Farmers of Ontario and Grain Farmers of Quebec (Producteurs de grains du Québec), representing over 50,000 grains and ...

WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced the ...

NEW YORK, April 13, 2022 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”), an innovative medical device company offering patented, best-in-class, single use smart safety syringe products, today announced the ...

MADISON, Wis., April 13, 2022 (GLOBE NEWSWIRE) -- Sonic Foundry Inc. (Nasdaq: SOFO), the trusted leader in video capture, management and streaming solutions as well as virtual and hybrid events, ...

SINGAPORE, April 12, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire  – Aura FAT Projects Acquisition Corp. (the “Company”) announced today that it priced its initial public offering of $100,000,000, consisting of ...

SINGAPORE, April 11, 2022 (GLOBE NEWSWIRE) -- Genius Group Limited (“Genius Group” or the “Company”) today announced the pricing of its initial public offering of 3,272,727 ordinary shares at a ...

HOUSTON--(BUSINESS WIRE)--Camden Property Trust (NYSE:CPT) today announced it has priced a public offering of 2,900,000 common shares for gross proceeds of approximately $493 million. The offering is expected to close ...

NEW YORK, March 31, 2022 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel ...